Multiple Myeloma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Based on these data, we conclude that SPAN-Xb is a novel member of the family of cancer/testis antigens aberrantly expressed by, and capable of inducing, immune responses in patients with multiple myeloma and other hematologic malignancies.
|
12393489 |
2003 |
Chronic Lymphocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we have used a pair of sequence-specific primers in reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis to demonstrate that the X-linked gene encoding SPAN-Xb is expressed in multiple myeloma and other hematologic malignancies such as chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML).
|
12393489 |
2003 |
Leukemia, Myelocytic, Acute
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we have used a pair of sequence-specific primers in reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis to demonstrate that the X-linked gene encoding SPAN-Xb is expressed in multiple myeloma and other hematologic malignancies such as chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML).
|
12393489 |
2003 |
Myeloid Leukemia, Chronic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we have used a pair of sequence-specific primers in reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis to demonstrate that the X-linked gene encoding SPAN-Xb is expressed in multiple myeloma and other hematologic malignancies such as chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML).
|
12393489 |
2003 |
Hematologic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In the present study, we have used a pair of sequence-specific primers in reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis to demonstrate that the X-linked gene encoding SPAN-Xb is expressed in multiple myeloma and other hematologic malignancies such as chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML).
|
12393489 |
2003 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
The data herein suggest that the SPAN-X protein may be a useful target in cancer immunotherapy.
|
14734458 |
2004 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
The data herein suggest that the SPAN-X protein may be a useful target in cancer immunotherapy.
|
14734458 |
2004 |
melanoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Immunoperoxidase labeling of melanoma cells and tissue sections demonstrated SPAN-X protein localization in the nucleus, cytoplasm, or both.
|
14734458 |
2004 |
Skin Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Significantly, the incidence of SPAN-X-positive immunostaining was greatest in the more aggressive skin tumors, particularly in distant, nonlymphatic metastatic melanomas.
|
14734458 |
2004 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Human sperm protein associated with the nucleus on the X chromosome (SPANX) genes comprise a gene family with five known members (SPANX-A1, -A2, -B, -C, and -D), encoding cancer/testis-specific antigens that are potential targets for cancer immunotherapy.
|
14973187 |
2004 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
Human sperm protein associated with the nucleus on the X chromosome (SPANX) genes comprise a gene family with five known members (SPANX-A1, -A2, -B, -C, and -D), encoding cancer/testis-specific antigens that are potential targets for cancer immunotherapy.
|
14973187 |
2004 |
Multiple Myeloma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
In this study, we determined the mechanisms regulating SPAN-Xb expression in MM.
|
16187275 |
2006 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Tumor cells were treated with 5-azacytidine and a panel of cytokines were used to determine their ability to induce SPAN-Xb expression.
|
16187275 |
2006 |
Malignant neoplasm of prostate
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We speculate that the predisposition to prostate cancer in X-linked families is an example of a genomic disease caused by a specific architecture of the SPANX gene cluster.
|
16251457 |
2005 |
Prostate carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We speculate that the predisposition to prostate cancer in X-linked families is an example of a genomic disease caused by a specific architecture of the SPANX gene cluster.
|
16251457 |
2005 |
Seminoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, these data suggest that the SpanX protein family is not exclusively expressed post-meiotically and that seminomas and embryonal carcinomas may originate from SpanX-positive carcinoma-in-situ cell.
|
16390498 |
2006 |
Embryonal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, these data suggest that the SpanX protein family is not exclusively expressed post-meiotically and that seminomas and embryonal carcinomas may originate from SpanX-positive carcinoma-in-situ cell.
|
16390498 |
2006 |
Multiple Myeloma
|
0.030 |
Biomarker
|
disease |
BEFREE |
SPAN-Xb is a novel cancer-testis antigen in multiple myeloma.
|
17036333 |
2006 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The function of SpanX proteins is unknown, evidence is accumulating to suggest their involvement in tumorigenesis.
|
17204091 |
2006 |
Germ cell tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of SpanX mRNA in testicular germ cell tumors.
|
17204091 |
2006 |
Testicular Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results showed that SpanX mRNA is present in TGCT, confirming transcriptional activity of these genes in such tumors.
|
17204091 |
2006 |
Malignant neoplasm of prostate
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutational analysis of SPANX genes in families with X-linked prostate cancer.
|
17373721 |
2007 |
Prostate carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutational analysis of SPANX genes in families with X-linked prostate cancer.
|
17373721 |
2007 |
Malignant neoplasm of testis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The SPANX genes encode cancer-testis (CT) specific antigens.
|
17373721 |
2007 |
melanoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
A statistical significant difference for a particular class of SPANX-C gene was found comparing patients with melanoma and controls (P=0.011).
|
18626316 |
2008 |